| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_326b425bb0078d795540683312fbb4df
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3d4242c390a562d7e9951785a2754bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_86d1a48b6902862a70e32485d9e1be36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca474b61a96dfcd636a0c0b4eb087868 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 |
| filingDate |
2007-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9adfc62ffcc8ffe366dc80947a011018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb0e03670a1ccd4a4d3a40a10776ed70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_138ff9a58356b78daac52ad07eee74d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24ebb3f4856bde6226be439a847d4e5c |
| publicationDate |
2009-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009202569-A1 |
| titleOfInvention |
Prophylactic/Therapeutic Agent for Cancer |
| abstract |
The present invention provides a preventative/therapeutic agent for cancer capable of selectively and effectively killing cancer cells. A medicament of the present invention prepared by combining at least one selected from a substance that inhibits the activity of an enzyme belonging to the acyl-CoA synthase family and a substance that inhibits expression of a gene for an enzyme belonging to the acyl-CoA synthase family, with at least one selected from a substance that inhibits the activity of fatty acid synthase and a substance that inhibits expression of a fatty acid synthase gene and the like can be used as a preventative/therapeutic agent for cancer capable of selectively and effectively killing cancer cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9346769-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113876958-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546432-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8450350-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013210890-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112587664-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9220723-B2 |
| priorityDate |
2006-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |